Table 30.
Toxidromes.
| N (%)a | |
|---|---|
| Sedative-hypnotic | 770 (10.7) |
| Anticholinergic | 437 (6.1) |
| Sympathomimetic | 289 (4.0) |
| Serotonin syndrome | 186 (2.6) |
| Opioid | 184 (2.6) |
| Alcoholic ketoacidosis | 71 (1.0) |
| Sympatholytic | 53 (0.7) |
| Washout syndrome | 25 (0.3) |
| Cholinergic | 10 (0.1) |
| NMS | 7 (0.1) |
| Anticonvulsant hypersensitivity | 5 (< 0.1) |
| Miscellaneousb | 7 (0.1) |
| Total | 2044 (28.5) |
NMS neuroleptic malignant syndrome
aPercentage based on the total number of cases reported to the Registry in 2019 (N = 7177)
bIncludes overlap syndromes and cannabinoid hyperemesis